Signed in as:
Signed in as:
The Cold Agglutinin Disease Foundation (CADF) has obtained the invaluable endorsement of four distinguished physicians who specifically support and encourage our establishing this dedicated non-profit foundation for advancing education and
research about CAD.
Sigbjørn Berentsen, MD, PhD Hematologist and Researcher Dept.
Research and Innovation, Haugesund Hospital, Norway
Sigbjørn Berentsen MD, PhD is a CAD Foundation Medical Advisor; a Consultant Hematologist and Senior Researcher, Department of Research and Innovation, Haugesund Hospital, Haugesund, Norway. He is interested in autoimmune hemolytic anemia, lymphoproliferative disorders, and complement-mediated diseases. His current main field of research is cold agglutinin disease (CAD), for which he has authored most of the published studies of B-cell directed therapies and coauthored some studies of complement-directed therapies.
Richard R. Furman, MD Hematology/Oncology
Weill Cornell Medicine
New York Presbyterian Hospital
Dr Richard Furman is a member of the Lymphoma/Myeloma Service in the Division of Hematology/Oncology at the New York Weill Cornell Medical Center. Board certified in internal medicine, hematology, and oncology, he is head of the CLL and Waldenstrom's Macroglobulinemia program at Weill Medical College and focuses on identifying new and promising therapies for patients with CLL and WM.
Along with collaborators at Columbia Presbyterian, Johns Hopkins, Roswell Park Cancer Institute, and Ohio State University, Furman has initiated the Waldenstrom's Research Consortium in order to enhance treatment and understanding of Waldenstrom's macroglobulinemia.
Dr. Joseph E. Kiss is a hematologist in Pittsburgh, Pennsylvania and is affiliated with multiple hospitals in the area, including UPMC Presbyterian Shadyside and UPMC Magee-Womens Hospital. He received his medical degree from Georgetown University School of Medicine and has been in practice for more than 20 years.
SPECIALITY - Hematology
Hematologists specialize in diseases of the blood, spleen and lymph glands, treating such conditions as anemia, clotting disorders, sickle cell disease, hemophilia, leukemia and lymphoma.
Roy E. Smith, MD, is a professor of medicine at the University of Pittsburgh School of Medicine in the Division of Hematology/Oncology. He specializes in bleeding and thrombotic disorders.
Dr. Smith is board-certified in internal medicine, medical oncology, and hematology.
All four are notable and recognized in the field of CAD treatment and research.